OVX836 a Recombinant Nucleoprotein Vaccine Inducing Cellular Responses and Protective Efficacy Against Multiple Influenza a Subtypes

npj Vaccines - United Kingdom
doi 10.1038/s41541-019-0098-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity Against H5N1 and H1N1 Subtypes of Influenza a Virus

PLoS ONE
Multidisciplinary
2012English

Cross-Protective Immunity Against Influenza a/H1n1 Virus Challenge in Mice Immunized With Recombinant Vaccine Expressing HA Gene of Influenza a/H5n1 Virus

Virology Journal
VirologyInfectious Diseases
2013English

Generation and Protective Efficacy of a Cold-Adapted Attenuated Avian H9N2 Influenza Vaccine

Scientific Reports
Multidisciplinary
2016English

Toward a Broadly Protective Influenza Vaccine

Journal of Clinical Investigation
Medicine
2008English

Protective Efficacy of a Human Endogenous Retrovirus Envelope-Coated, Nonreplicable, Baculovirus-Based Hemagglutin Vaccine Against Pandemic Influenza H1N1 2009

PLoS ONE
Multidisciplinary
2013English

Intranasal Flu Vaccine Protective Against Seasonal and H5N1 Avian Influenza Infections

PLoS ONE
Multidisciplinary
2009English

Rational Design of a Recombinant Subunit Influenza Vaccine

English

Efficacy of Trivalent, Cold-Adapted, Influenza Virus Vaccine Against Influenza a (Fujian), a Drift Variant, During 2003–2004

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2007English

Influenza a Virus Nucleoprotein (NP)

Science-Business eXchange
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy